Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Diabetes ; 8(3): 398-404, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-25990785

RESUMEN

BACKGROUND: The aim of the present study was to examine the effect of aldehyde modification on antioxidant enzyme activity in diabetic patients. METHODS: The activity of commercially available antioxidant enzymes (catalase, glutathione peroxidase [GPx], and Cu,Zn-superoxide dismutase [SOD]) was determined in vitro prior to and after aldehyde modification. The activity of erythrocyte Cu,Zn-SOD was assayed in blood drawn from healthy donors, diabetic patients with decompensated carbohydrate metabolism, and diabetic patients after glucose-lowering therapy. RESULTS: In vitro aldehyde modification had no effect on catalase activity, but diminished GPx and Cu,Zn-SOD activity. In diabetic patients with decompensated carbohydrate metabolism, glucose-lowering therapy significantly increased Cu,Zn-SOD activity, the effect being especially pronounced after administration of metformin. CONCLUSIONS: It is likely that metformin antagonizes the aldehyde-induced inhibition of erythrocyte Cu,Zn-SOD in diabetic patients more effectively than sulfonylurea drugs.


Asunto(s)
Aldehídos/farmacología , Antioxidantes/química , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/enzimología , Eritrocitos/enzimología , Animales , Antioxidantes/metabolismo , Estudios de Casos y Controles , Bovinos , Diabetes Mellitus Tipo 2/sangre , Eritrocitos/efectos de los fármacos , Femenino , Glioxal/farmacología , Humanos , Hipoglucemiantes/uso terapéutico , Masculino , Malondialdehído/farmacología , Metformina/uso terapéutico , Persona de Mediana Edad
2.
Mol Cell Biochem ; 396(1-2): 79-85, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25064448

RESUMEN

Under some pathological conditions, the natural dicarbonyl compounds can accumulate in the blood. The examples are malonyldialdehyde (MDA) formed as a secondary product of lipid peroxidation of unsaturated fatty acids during atherosclerosis, and glyoxal (GOX), a homolog of MDA, which accumulates during glucose autoxidation in patients with diabetes mellitus. This study compared the influence of both dicarbonyl compounds on low-density lipoproteins (LDL) and the membrane of endotheliocytes. In comparison with GOX, MDA induced more pronounced changes in physical and chemical properties of LDL particles. On the other hand, GOX-modified LDL particles were more prone to oxidation and aggregation than MDA-modified LDL. Incubation of endotheliocytes with MDA increased cell mechanical stiffness in contrast to incubation with GOX, which decreased it.


Asunto(s)
Células Endoteliales/efectos de los fármacos , Glioxal/farmacología , Lipoproteínas LDL/química , Malondialdehído/farmacología , Membrana Celular/efectos de los fármacos , Células Cultivadas , Electroforesis en Gel de Agar , Células Endoteliales/química , Células Endoteliales/metabolismo , Endotelio Vascular/citología , Glioxal/química , Humanos , Peróxidos Lipídicos/química , Lipoproteínas LDL/sangre , Malondialdehído/química , Reología/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...